https://eureka.patsnap.com/resources/blog/rd-blog/sequence-read-compression-algorithm-patent-landscape-patent-landscape/ · Patsnap · data cut-off 2026-08-31 · downloaded from the live page
Patent Landscape · Genomics & Bioinformatics

Sequence Read Compression Algorithm Patents: Who Files, What They Claim, and Where the Field Is Still Open

A patent landscape review of sequencing read and genomic data compression algorithms: filing trends since 2015, the leading assignee, technology composition across eight IPC subclasses, and where claim space remains open

74
Published Records
-96%
Filing Growth 2021→2024
US
Leading Jurisdiction
18
Active Filers Ranked

Filing growth = 2021 (23 records) → 2024 (1); 2024 is the last year we treat as complete.

Check your own idea
Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Overview

What this patent landscape covers

This landscape draws on 74 published records matching sequencing read or genomic data compression algorithms, filed between 2015 and the 2026 data cut-off. It maps who is filing, what technical ground the claims occupy across eight IPC subclasses, and how filing activity has moved since the field's early years. The dataset treats each record as a patent family, which is the fairer counting unit because it neutralises repeat continuation filings and multi-jurisdiction duplicates of the same invention.

Coverage runs from a single 2011 filing through a 2021 peak of 23 records, tapering toward the present. Because publication typically lags filing by around 18 months, the most recent one to two years in any trend chart are undercounts, not necessarily a real drop-off in inventive activity.

Filing activity and technology composition, 2015-2026
  1. 1KONINKLIJKE PHILIPS NV32
  2. 2ARC BIO LLC11
  3. 3RAJANT HEALTH INC8
  4. 4GENOMSYS SA7
  5. 5LEIGHTON3
  6. 6INTERNATIONAL BUSINESS MACHINE CORPORATION3
  7. 7PENG JIAN3
  8. 8YU YUN WILLIAM3
  9. 9YORUKOGLU DENIZ3
  10. 10GURULOGIC MICROSYST2
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Sequence Read Compression Algorithm Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Let an AI agent run this analysis on your own technology

Pick a task. Every answer cites the patents behind it.

10,000 free credits to start
The data

Filing trends and technology composition

Two views of the same 74-record dataset: how filing activity has moved year over year, and which technical classes the claims actually sit in.

A sharp peak, then a fall still being backfilled by publication lag

Filings rose from a single record in 2011 to a peak of 23 in 2021, then declined to 1 by 2024 -- a -96% move the evidence supports directly. Because publications take roughly 18 months to appear after filing, 2025 and 2026 figures are not yet complete and should not be read as confirmation the field has gone quiet.

A sharp peak, then a fall still being backfilled by publication lag06131925120112013201520172019232021202320250Most recent year is partial — publication lag means later filings are not yet visible.

Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.

Bioinformatics framing dominates over generic compression coding

G16B (bioinformatics) appears on 83.8% of the 74 records and G06F (digital data processing) on 50.0%, meaning most claims are written as bioinformatics or computing workflows rather than pure compression method. Dedicated coding and code-conversion class H03M covers just 10.8%, and adjacent classes -- C12Q at 14.9%, H04L at 5.4%, A61B and H04N each at 4.1%, and G01N at 2.7% -- show where the technique intersects sequencing hardware, transmission and diagnostics without being the primary claim focus there.

Bioinformatics framing dominates over generic compression codingG16B · Bioinformatics6283.8%G06F · Electric digital data processi…3750.0%C12Q · Measuring & testing involving …1114.9%H03M · Coding & code conversion810.8%H04L · Digital information transmissi…45.4%A61B · Diagnosis & surgery34.1%H04N · Pictorial communication (video…34.1%G01N · Material analysis & testing22.7%Other45.4%

Shares are the percentage of the 74 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Sequence Read Compression Algorithm Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Sequence Read Compression Algorithm Patent Landscape with Eureka

This page is one run against one query. Ask Eureka your own question about sequence read compression algorithm patent landscape and every answer comes back with the patent numbers behind it.

Try Eureka
Representative filing

A representative filing in this space

Featured record
US20230377692A12023-11-23

Methods and systems for storing genomic data in a file structure comprising an information metadata structure

KONINKLIJKE PHILIPS N.V.

The filing describes a method for storing a genomic dataset within a file structure paired with an information metadata structure -- covering annotation tables with user profile and permission data, analytics information to verify data reproducibility, access history for traceability, and linkage information tying the annotation table to the underlying dataset.Abstract text shown as published; reference numerals from the original drawing are retained.

US20230377692A1 — patent drawing 1US20230377692A1 — patent drawing 2
View full record
Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Sequence Read Compression Algorithm Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis


  
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Reading the numbers

What the filing pattern signals

Three figures from this dataset carry more decision-relevant weight than the raw record count: the gap at the top of the ranking, the shape of the filing curve, and the split between bioinformatics and generic coding claims.

Concentration at the top
32 vs 3
leader's filings vs fifth place

One dominant filer, then a long tail

The leading assignee holds 32 records against 3 at fifth place and 2 at tenth, in a ranking of 18 companies and inventors. That gap suggests one organisation built an early, broad filing position while the rest of the field holds narrower, more scattered claims.

Ranking covers 18 assignees, not a top-50 or top-100 cut.
Filing trajectory
-96%
2021 to 2024, 23 → 1 records

A sharp peak in 2021, then a steep drop

Filings climbed to a peak of 23 records in 2021 before falling to 1 by 2024, a -96% move over that three-year span. Because publication lags filing by around 18 months, 2025-2026 counts are still incomplete and should not be read as evidence the field has stopped moving.

Do not extend this trend past 2024 using later, partial years.
Claim framing
83.8% vs 10.8%
G16B bioinformatics vs H03M coding, of 74 records

Bioinformatics workflow claims outnumber pure coding claims

G16B appears on 83.8% of the 74 records in scope, while dedicated coding and code-conversion class H03M covers just 10.8%. Most applicants are claiming the compression step as part of a genomic data pipeline rather than as a standalone codec, which shapes where a freedom-to-operate search needs to look first.

Shares exceed 100% combined because records can carry multiple IPC classes.
Filing venues
19 US filings
of the receiving-office counts given

US and EPO lead receiving offices, PCT and India close behind

The United States received 19 filings, EPO 12, WIPO/PCT 11, India 10, Israel 8 and Australia 6. The PCT and India counts suggest applicants are routing a meaningful share of these filings toward broader or emerging-market coverage rather than concentrating solely on the US and Europe.

Counts are receiving-office totals, not unique-family shares.
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to sequence read compression algorithm patent landscape, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Derived observations on the same dataset. Derived from a Patsnap search on Sequence Read Compression Algorithm Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Next steps

Where to take this analysis

The dataset points to a field with one entrenched filer, a filing curve still filling in for recent years, and claim territory concentrated in bioinformatics workflow rather than generic coding. The next steps depend on whether the goal is freedom-to-operate, licensing, or identifying where to file next.

Map the leader's actual claim scope

A 32-record filer with this kind of gap over the rest of the ranking is worth a claim-by-claim read, not just a count. Understanding exactly what is claimed narrows where new filings can safely sit.

Explore the leader's portfolio in Eureka

Watch the H03M and H04L intersections

Coding-class and transmission-class overlaps sit well below the bioinformatics share, at 10.8% and 5.4% of the 74 records respectively. That gap is where a compression-first claim, rather than a workflow claim, may still have room.

Run a white-space search in Eureka

Track the next 18 months of publications

The 2024 figure is the last complete year; 2025 and 2026 will keep filling in as filings publish. Re-checking this trend in six to twelve months will show whether the 2021 peak was a one-off cycle or the start of a longer plateau.

Set an alert in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Sequence Read Compression Algorithm Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions about sequence read compression patents

Answers are grounded in the same dataset. Derived from a Patsnap search on Sequence Read Compression Algorithm Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Sequence Read Compression Algorithm Patent Landscape in depth with Eureka

Go past this page: query the whole sequence read compression algorithm patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.